Your browser doesn't support javascript.
loading
Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma.
Liu, Chuanxu; Ding, Xinyu; Li, Gaoyang; Zhang, Youping; Shao, Yubao; Liu, Linyi; Zhang, Wenhao; Ma, Yujie; Guan, Wenbin; Wang, Lifeng; Xu, Zhongli; Chang, YungTing; Zhang, Yongqiang; Jiang, Biao; Yin, Qianqian; Tao, Rong.
Affiliation
  • Liu C; Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Ding X; Department of Hematology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Li G; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Zhang Y; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Shao Y; Department of Hematology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Liu L; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Zhang W; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Ma Y; Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Guan W; Department of Hematology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Wang L; Department of Hematology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Xu Z; Department of Pathology, Xinhua Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Chang Y; Department of Pathology, Xinhua Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Zhang Y; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Jiang B; Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Yin Q; State Key Laboratory of Bioengineering Reactor, Shanghai Key Laboratory of New Drug Design and School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
  • Tao R; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
iScience ; 26(8): 107369, 2023 Aug 18.
Article in En | MEDLINE | ID: mdl-37539026
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2023 Document type: Article Affiliation country: Country of publication: